Pharma Deals Review, Vol 2002, No 31 (2002)

Font Size:  Small  Medium  Large

Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care

Business Review Editor

Abstract


Senetek entered an agreement with Douglas Pharmaceuticals to market and distribute Senetek’s premier erectile dysfunction product Invicorp™ in New Zealand. Senetek also entered into an agreement with Shaklee for worldwide licensing, distribution and marketing of Senetek’s Kinetin, a cytokinin used to reduce the signs of ageing.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.